← Back to guidelines
Pediatrics1 paper

Pierson syndrome

Last edited: 4/16/2026

Overview

Pierson syndrome is a rare genetic disorder characterized by loss-of-function mutations in the laminin beta2 (LAMB2) gene, leading to a spectrum of ocular and renal abnormalities, prominently featuring microcoria and renal dysfunction 1.

Diagnosis

  • Key Ocular Findings: Microcoria (most characteristic), posterior embryotoxon, megalocornea, iris hypoplasia, cataract, abnormal lens shape, posterior lenticonus, persistent fetal vasculature, retinal detachment, variable axial lengths, and glaucoma 1.
  • Renal Function Assessment: Essential due to associated renal involvement; consider renal imaging and function tests 1.
  • Genetic Testing: Molecular confirmation through analysis of LAMB2 mutations 1.
  • Management

  • Ophthalmological Monitoring: Regular follow-ups to manage ocular complications such as glaucoma and retinal detachment 1.
  • Renal Management: Tailored to specific renal issues, potentially including dialysis or transplantation depending on severity 1.
  • Symptomatic Treatment: Address specific symptoms like cataracts with surgical intervention as needed 1.
  • Special Populations

  • Pediatrics: Early detection and monitoring crucial due to variability and potential for early ocular presentation 1.
  • Key Recommendations

  • Consider Pierson syndrome in newborns presenting with marked bilateral microcoria and investigate renal function 1 (Evidence: Moderate).
  • Regular ophthalmologic evaluations are essential to manage the wide range of ocular abnormalities 1 (Evidence: Moderate).
  • Genetic testing for LAMB2 mutations should be performed for definitive diagnosis 1 (Evidence: Moderate).
  • References

    1 Bredrup C, Matejas V, Barrow M, Bláhová K, Bockenhauer D, Fowler DJ et al.. Ophthalmological aspects of Pierson syndrome. American journal of ophthalmology 2008. link

    Original source

    1. [1]
      Ophthalmological aspects of Pierson syndrome.Bredrup C, Matejas V, Barrow M, Bláhová K, Bockenhauer D, Fowler DJ et al. American journal of ophthalmology (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG